Can Vaccines be Allocated on Antiracist Terms?
There is no question that COVID-19 has disproportionately affected nonwhite communities. And “vaccine sovereignty” – the idea, embraced by the US and Europe, that individual governments should use public funding to obtain priority access to potential vaccines – could keep it that way.
https://prosyn.org/MySA5xf
NEW YORK – A safe and effective vaccine could play a significant role in mitigating the COVID-19 pandemic. Yet, even if such a vaccine is found, it is highly unlikely that a sufficient number of doses could be produced in the next 2-3 years to ensure equitable access for everyone. So, when a COVID-19 vaccine becomes available, who should get it first?